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Summary
Background The number of qualitative studies on eczema has increased rapidly in
recent years. Systematically reviewing these can provide greater understandings
of people’s perceptions of eczema and eczema treatments.
Objectives We sought to systematically review and thematically synthesize qualita-
tive studies exploring views and experiences of people with eczema and par-
ents/carers of children with eczema.
Methods We searched MEDLINE, EMBASE, PsycINFO and CINAHL from the earliest
date available to February 2019. We selected papers focusing on views and expe-
riences of eczema and eczema treatments, and barriers/facilitators to eczema self-
management. We excluded papers focusing on health service provision models
or health professionals’ views.
Results We synthesized 39 papers (reporting 32 studies) from 13 countries. We
developed four analytical themes: (1) Eczema not viewed as a long-term condi-
tion; (2) Significant psychosocial impact not acknowledged by others; (3) Hesi-
tancy (patient/carer uncertainty) about eczema treatments; and (4) Insufficient
information and advice. Our findings suggest that people with eczema and their
carers experience frustration at having to manage a condition that is often seen
by others as mundane but has significant psychosocial impact and is difficult to
manage due to concerns about, and burden of, treatment. This frustration can be
exacerbated by experiences of conflicting and/or insufficient information and
advice from health professionals, family and others.
Conclusions Effective self-management of eczema could be supported by addressing
beliefs and concerns about treatments; seeking positive ways to promote a ‘con-
trol not cure’ message; acknowledging psychosocial impacts of eczema and treat-
ment burden; and providing clear consistent advice or signposting towards
reliable information.
What is already known about this topic?
• Eczema is a common skin condition that can have a substantial impact on quality
of life.
• One of the most common causes of treatment failure in mild-to-moderate eczema
is the underuse of topical treatments.
• Increasingly, qualitative approaches have been adopted to understand people’s
views and experiences of eczema and eczema treatment, which can help to address
common barriers and support effective self-management.
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What does this study add?
• We found a large volume of qualitative studies giving valuable insights into peo-
ple’s perceptions of eczema.
• Synthesizing these studies highlights many recurring themes and adds further
insights, for instance different perceptions between adults with eczema and parents
of children with eczema on its long-term nature.
• Eczema can be difficult to manage due to treatment hesitancy and burden and mis-
perceptions about the long-term nature of eczema.
• Hesitancy or concern about eczema treatments is made worse by insufficient and
inconsistent information and advice.
What are the clinical implications of the work?
• Health professionals need to address common treatment beliefs and concerns and
seek positive ways to promote a ‘control not cure’ message to support effective
ongoing self-management.
• Acknowledging the significant psychosocial impacts of eczema and burdensome
nature of treatment and providing clear consistent information and advice or sign-
posting towards credible information may address people’s concerns that distress
caused by the condition is not taken seriously.
Eczema is common and can have substantial impact on quality
of life due to itch and sleep disturbance.1 Eczema management
involves applying topical treatments and avoiding triggers
(e.g. soap).2 National Institute for Health and Care Excellence
guidance2 suggests the main cause of treatment failure is due
to the underuse of topical treatments.3 Treatment usage is
related to people’s understanding of their condition and its
treatment, as well as their perceived need for treatments and
concerns about any negative effects.4 Surveys have found that
people with eczema worry about using topical corticos-
teroids,5,6 yet relatively little is known about the reasons
behind this.
Qualitative research seeks to gain a comprehensive under-
standing of people’s lived experiences of a condition. Greater
understanding of their perspectives on treatments may help to
promote a ‘shared understanding’ and identify narratives that
could mitigate against increasingly polarized views about
eczema treatments that have emerged between patients/carers
and health professionals.7,8
Synthesizing the results from existing qualitative research
studies helps to generate new valuable insights into people’s
beliefs and concerns, and their support and information
needs.9,10 We aimed to synthesize existing qualitative studies
exploring the views and experiences of eczema and eczema
management among people with eczema and parents/carers of
children with eczema.
Methods
Thematic synthesis was used to synthesize the review findings.11
We followed the ENTREQ statement12 to facilitate reporting.
Selection criteria and search strategy
We included papers that focused primarily on the views and
experiences of eczema and eczema treatments, and barriers/fa-
cilitators to eczema self-management. To be eligible for inclu-
sion, studies must have used qualitative data collection and
analysis methods. Mixed methods studies were included if they
had a substantive qualitative component. Papers that focused
solely on health service provision models or the views/experi-
ences of health professionals were excluded (Table 1).
Five electronic databases were searched using a comprehen-
sive search strategy (Table S1; see Supporting Information):
MEDLINE (1946 to week 2 of February 2019); EMBASE (1980
to 27 February 2019); PsycINFO (1887 to week 3 of February
2019) and CINAHL (1982 to week 4 of February 2019). The
last search was conducted on 27 February 2019. There were no
language or date restrictions. We reviewed the references of
each included paper, conducted forward citation tracking and
contacted experts in the field to identify other eligible papers.
Multiple papers from a single study were included if each pre-
sented unique data. Two eligible studies (published in German
and Korean) were translated into English by a professional transla-
tor. Three authors independently screened all titles and abstracts
against the inclusion criteria (E.T., N.F. plus either S.W. or I.M.).
Comprehensiveness of reporting
Two authors (E.T., D.G.) and two student research assistants
(N.W., L.S.) independently extracted data and appraised the
reporting quality of identified studies. We used the COREQ
(Consolidated Criteria for Reporting Qualitative Research)13
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checklist to systematically examine the comprehensiveness of
reporting to judge the trustworthiness and transferability of
the studies. Any discrepancies were resolved by consensus. No
studies were excluded on grounds of quality.
Thematic synthesis
We imported the findings from each paper (including partici-
pants’ data and author interpretation of findings) into NVivo
version 12. Thematic synthesis11 comprises three distinct
stages: line-by-line coding, developing descriptive themes
from initial codes and generating analytic themes that ‘go
beyond’ the descriptive themes. One author (E.T.) conducted
line by line coding then compared and categorized initial
codes to create a set of descriptive themes that represented
the content and meaning of the individual studies. A detailed
coding manual ensured transparent and systematic data cod-
ing. Coding, descriptive themes and subthemes were dis-
cussed with, and iteratively developed by, coauthors (M.S.,
A.R., M.J.R., K.S.T., L.Y., K.S., D.G., K.G.) to offer diverse
inferences and interpretation of the data, and to facilitate the
generation of analytic themes.
Results
Our searches yielded 2241 records (1569 after duplicates
removed). Eligibility screening identified 39 papers reporting
32 studies for inclusion (Figure 1).
Study characteristics and comprehensiveness of
reporting
The included studies explored the views and experiences of
1007 participants including 405 parents/carers of children
with eczema, 252 people with eczema and 350 online forum
users. Study characteristics are presented in Table S2 (see Sup-
porting Information).14–52 The comprehensiveness of report-
ing was mixed. Participant selection, setting, data analysis and
findings were well reported, while interviewer characteristics
and relationship with participants were poorly reported
(Table S3; see Supporting Information).14–52
Synthesis of findings
Our synthesis identified four overarching analytical themes:
(1) Eczema not viewed as a long-term condition; (2) Signifi-
cant psychosocial impact of eczema not acknowledged by
others; (3) Hesitancy (patient/carer uncertainty) about eczema
treatments; and (4) Insufficient information and advice
about eczema (Figure 2). Table 2 presents quotes from
study participants to illustrate each theme and sub-
theme.18,20,21,27,28,30,32,33,37,39–42,50,51 Further theme tables
are provided in Table S4 (see Supporting Information).14–52
Eczema not viewed as a long-term condition
A common perception highlighted in the synthesis was that
people with eczema often do not view eczema as a chronic
condition requiring long-term treatment. Research with parents
and children identified hopes of outgrowing eczema and/or
experiences of being told they would outgrow eczema. Partici-
pants hoped to discover an underlying cause of eczema to
‘cure’ eczema, which further contributed to a perception of
eczema as short term. This had implications for the perceived
necessity of long-term treatment and was linked with frustra-
tion at the perceived ‘simplicity’ of eczema management in tar-
geting symptom control rather than underlying causes.
Desire to seek an underlying cause and potential ‘cure’
for eczema
A diverse range of beliefs about underlying causes of eczema was
reported, including exogenous factors (dietary allergens, chemi-
cals, medication and water type) and endogenous factors (genetic
disposition, stress/psychological factors). A common belief
among families was that dietary avoidance might represent a
potential ‘cure’; many described having tried this and described
frustration with healthcare professionals’ perceived lack of interest
in exploring dietary causes.14,18,21–23,26,28,31,32,41,50–52
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Population
of interest
Children with eczema
Young people with eczema
Parents/carers of children
with eczema
Adults with eczema
Health
professionals’
views only
Exposure
of interest
Eczema and eczema self-care
• Eczema
• Emollient use
• Topical corticosteroid use
• Topical calcineurin inhibi-
tor use
• Avoidance of triggers
• Emotional/stress manage-
ment
• Reducing scratching
• Psychosocial impact of
eczema only
• Accessing health services,
treatment, dealing with
healthcare professionals
Models of health
service provision
Outcome
of interest
Patients and parent/carers’
beliefs, views, concerns,
understandings and
experiences
Study
design
Qualitative (including
ethnography, grounded
theory, phenomenology,
focus groups, interviews and
participant observation)
Mixed methods
Quantitative
Reviews
Not primary
research
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Frustration at perceived simplicity of eczema treatment
Frustrations were identified with treatments viewed as only
‘controlling’ eczema rather than providing a ‘cure’.27,31,33,37,40
One study37 outlined a paradox of complexity and simplicity,
whereby living with eczema is experienced as complex in terms
of impact and treatment burden, but people perceive that they
are offered only simple ‘Band-Aid’ solutions that do not treat
Records idenfied through database 
searching (MEDLINE, EMBASE, PsycINFO, 
CINAHL)
(n = 2241)
Addional records idenfied through 
other sources 
(n = 0)
Records aer duplicates removed 
(n = 1569)
Records screened based on 
tle and abstract 
(n = 1569)
Records excluded (n =1496)
• Not qualitave methods and qualitave 
analysis (807)
• Not focused on eczema/eczema self-
care (481)
• Not primary qualitave research (196)
• Focused on health professionals’ views 
(12)
Full-text arcles assessed for 
eligibility 
(n = 73)
Full-text arcles excluded (n = 34)
• Not focused on eczema/eczema self-
care (12)
• Not qualitave methods and qualitave 
analysis (11)
• Not primary qualitave research (8)
• Focused primarily on views of health- 
care services (3)
Papers included in qualitave 
synthesis
(n = 39)
Papers excluded as a result of quality 
assessment (n = 0)
Potenal papers to be 
included in review
(n = 39)
Figure 1 PRISMA flowchart for systematic review and qualitative synthesis.
© 2020 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists
British Journal of Dermatology (2020)
4 People’s view of managing eczema, E. Teasdale et al.
the underlying cause. Such beliefs represent potential challenges
to adherence to long-term eczema treatments.
Significant psychosocial impact of eczema not
acknowledged by others
People across studies were frustrated at the lack of recognition
and acknowledgment by both health professionals and wider
society of the significant physical and emotional impacts of
eczema on people with eczema and their families.
Perceived impact on physical and emotional wellbeing
Physical impacts of eczema commonly described across studies
were persistent itch, pain and discomfort due to dry skin,
chronic sleep disruption for people with eczema, and parental
exhaustion from attending to their child’s needs at night.
Significant emotional impacts of eczema were experiencing
distress, low mood and self-esteem due to feeling stigmatized
and self-conscious about their appearance and feeling that they
do not fit a societal ideal of ‘perfect’ skin, and the resultant effect
this can have on relationships. Studies also highlighted the nega-
tive effect of dealing with others’ perceptions and distress expe-
rienced in response to intrusive comments or reactions by
strangers to visible eczema, such as fear of contagion. A sense of
blame, guilt and worry were common, especially parental feel-
ings of inadequacy in their ability to prevent the eczema, envy
of other parents with perceived ‘normal’ children and fears and
concerns about the impact on their child’s self-esteem and social
interactions.16–18,21,23,26–28,33,36,38,41,42,44,45,47–51
Eczema not viewed as 
a long-term condi on
Desire to seek an 
underlying cause 
and poten  ‘cure’ 
for eczema
Frustra on at 
perceived simplicity 
of eczema 
treatment
Hesitancy about 
eczema treatment 
Concerns about the 
perceived risk of 
topical 
cor costeroids
Uncertainty about 
appropriate use of 
topical 
cor costeroids
Concerns about the 
cons tuents of 
emollients
Doubts about 
effec eness of 
topical treatments
Strategies to 
overcome perceived 
difficu es and 
concerns
Receiving conflic ng 
and nega e advice 
about topical 
treatments
Significant 
psychosocial impact 
not acknowledged
Perceived impact on 
physical and 
emo onal well-
being
Perceived impact on 
everyday 
rou nes/family life
Prac cal barriers to 
topical treatment 
use
Perceived 
trivializa on/ 
dismissal of eczema 
by others 
Insufficient 
infor on and advice 
about eczema
Perceived 
subop mal eczema 
informa on 
provision
Figure 2 Components of key themes.
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Table 2 Illustrative quotes by theme
Theme and subtheme Representative quotes
Eczema not viewed as a long-term condition
Desire to seek an underlying cause and potential
‘cure’ for eczema
‘The condition of my AE child is getting worse. I try my best to relieve his suffering.
Some mothers have told me that the chlorine in the water supply and the water pipes
affects AE. So, I replaced the water pipes and use a filter, and his condition is getting
better now.’18
‘I just, I wanted to know really why was she getting it, was it diet orientated because it
seemed to crop up at the same time as I was weaning her, and I thought she might
have an allergy to milk or, you know that milk I was using, or perhaps some of the,
the fabric conditioners or, you know, or the baby bath I was using, something like
that.’21
Frustration at perceived simplicity of eczema
treatment
‘The frustrating thing with TCs [topical corticosteroids] is that they don’t really treat the
disease. They provide relief but they don’t heal.’40
‘I don’t like that it only treats the symptoms and not the cause of the problem.’33
Significant psychosocial impact of eczema not acknowledged by others
Perceived impact on physical and emotional
wellbeing
‘She hardly got any sleep, she scratched herself, and she was at a point where she
couldn’t keep up at school. She was totally exhausted, which affected her mood.’42
‘I sometimes feel so ugly when everything is stuck together, I am like a monster. I don’t
want anybody to see me and I don’t want to go out.’51
Perceived impact on everyday routines/family
life
‘There are many things which you have to give up. That is, I liked knitting and I liked
to cook and make pickles and jam. I was very, you know, active with my hands. I
don’t bother to do these things anymore because it’s far too troublesome.’37
‘The very fact the she does not sleep means that we very rarely go out. The few
occasions we do go out K’s grandma will baby-sit, but this [is] extremely tiring for her
and therefore we do not ask often’19
Practical barriers to topical treatment use
– Child resistance
– Time-intensive nature of eczema treatment
– Difficulties of using topical treatments out-
side of home environment
‘It is very difficult to apply the cream to my son as he always fights with me and runs
away from me when I am trying very hard to keep his skin moist. Sometimes I have to
wait and apply the cream at 2 am when he is asleep.’18
‘If I was having a bad day and it would take 2 hours in the morning just to cream her
up and to get the routine done, it was just . . . I was so exhausted and you’ve still got
to do everything else and life and fit it all in. It could be quite hard. . .’28
‘I think [the daycare providers are] limited on what they can and can’t do for a child
with eczema during the day. . . . That’s one of the most problems I have . . . to keep
shine to her, you have to apply lubrication all day.’20
In spite of relevant precautions at work, one participant had an eruption, interpreted as
work-related, from touching a door handle where a colleague could have left residue of
the allergen. ‘One can’t control other people’s actions [. . .] no matter how many labels
you read [. . .].’37
Perceived trivialization/dismissal of eczema by
others
‘There’s nobody else and they don’t understand how it is [. . .] They don’t even believe
before they see it, my coach thought I was exaggerating.’51
[Health professionals say] ‘No, no it’s just dry skin’, ‘Oh, it’s just eczema’. I don’t think
they realize how much children can suffer from it.’21
‘And then it got to the point where my mother actually took her in because I was
getting nowhere with the doctor, he kept on fobbing me off with rubbish, you know,
“She’ll grow out of it”, yeah but that doesn’t help now.’27
Hesitancy about eczema treatment
Concerns about the perceived risk of topical
corticosteroids
‘It makes your skin wither . . . Will they tell you later on that you shouldn’t use D . . .
fear that in a few years it could give you something . . . that we don’t know about for
now . . . medicine evolves.’40
‘My baby started getting eczema over the last month or so. My GP suggested [leave-on
emollient] and I am using loads of it, but I don’t think it’s doing anything. I asked the
GP if there’s anything else I can try because I thought it might be worth trying a mild
steroid cream, but my doctor advised against it because the risks (skin thinning)
outweigh the benefits.’32
Uncertainty about appropriate use of topical
corticosteroids
‘I did ask once what exactly is a thin layer?’33
‘I guess the question is when to use steroids. The doctors always said to only use them
for a few days at a time. When a patch flares up the steroids generally help within a
few days, but then we find that another small patch has flared up somewhere else on
his body so we end up using the cream for ages but in different places if that makes
sense.’32
(continued)
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Perceived impact on everyday routines/family life
Participants commonly reported changing behaviours and
modifying everyday routines in response to eczema symp-
toms, in a desire to avoid potential irritants and adhere to
treatment regimes.14–20,23,34,37,51 Studies highlighted partici-
pants’ experiences of restricting social activities, work activities
or career choices to prevent flare-ups. In contrast, a desire to
live an ‘ordinary’ life and not let eczema impact on routines
or behaviours was evident in some studies.
As well as restricting or giving up certain activities, a com-
mon impact among parents was dealing with the extra burden
on daily life of caring for a child with eczema.14–20,23,34 Many
parents described carrying out extra tasks to manage their
child’s eczema, e.g. applying topical treatments, extra washing
and cleaning, buying particular clothing.
Practical barriers to topical treatment use
Treatment burden and its impact on people with eczema and
family life was apparent along with a sense that this burden was
not acknowledged by others.14,15,18,20,28,37,41,49,50 A dominant
experience was around perceived difficulties in applying topical
treatments, particularly due to its time-intensive nature and
Table 2 (continued)
Theme and subtheme Representative quotes
Concerns about the constituents of emollients ‘My son uses emulsifying ointment as a protective layer for his skin. My approach would
be different if it were made of a different substance. Some are made from natural
materials but some are chemical products. I can distinguish between the two just by
smelling!’18
‘. . . I’m not into kind of putting loads of chemicals on them if I can possibly avoid it,
which is why I think in the end my solution was if it’s really bad I’ll use the cream but
otherwise I’ll just stay away from anything I put on his skin and look at diet first and
then kind of consider that.’27
‘Sometimes it’s annoying, especially in the morning, because greasy spots appear in my
trouser due to the creams.’50
‘. . . the other creams, we had a couple, I think it was E [ointment], I’m not sure, but it
was really thick, like Vaseline [ointment], they were quite difficult – they’re really
thick, greasy, really hard to apply, ’cos that ruined loads of clothes, so you had to wash
things. That was quite hard work at the beginning, I’d say.’30
Doubts about effectiveness of topical treatments ‘Sometimes we are advised to use steroids for x long . . . then as soon as it stops
everything flares up again. Not a long-term solution really.’41
‘At this moment, I feel like the effect is becoming weaker. Because as soon as I start to
reduce the amount, it comes straight back.’33
Strategies to overcome perceived difficulties and
concerns
– Distraction, disguising treatment
– Establishing a daily routine
– Personal adjustment of treatment regimes
‘I usually rub it on and let it dry for 2 seconds. [. . .] rub it on sort of like in a car wash.
Apply polish and dry.’39
‘Well, not everyone feels like this, right. I think it’s a habit, but with the mobile phone
you can set more than one alarm. I have begun to set it thrice a day. At least in the
evening, because then the phone hoots even if you have gone to bed. Well – put on
the cream and the gloves.’37
‘I don’t apply it until my comfort threshold has been exceeded and I’m all red and it
itches all over.’40
Receiving conflicting and negative advice about
topical treatments
‘I saw this one doctor who said that we should use the [mild topical corticosteroid] on
red inflamed skin and that we should use [potent topical corticosteroid] anywhere
where the skin is actually broken. But then I saw another GP who told me not to use
[potent topical corticosteroid] unless it is really bad because it is so strong and it
would damage the skin. Could anyone please give me a clear answer about when I
should use an emollient, or a mild steroid or a stronger steroid?’32
‘I was disappointed when the paediatrician said, “It’s nothing serious, but unfortunately,
we’ll have to use cortisone.” When he said “unfortunately”. . .’40
Insufficient information and advice about eczema
Perceived suboptimal eczema information
provision
‘I just wish that the GP at the beginning had recognized it more quickly and explained
more about the importance of emulsifying and, erm, proper use of the hydrocortisone
really, that’s the one thing that stands out.’21
‘It would be good if they showed you how to apply the cream, when collecting it for
the first time.’50
‘I kind of feel that . . . it’s not come back in, say, 2 months’ time and we’ll review
whether it’s making a difference or not . . . I have felt some of the time that I’m
making it up as I go along . . .’27
GP, general practitioner
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among parents of younger children, the challenge of child resis-
tance due to discomfort/pain/stinging or ‘just being a toddler’.
Some studies found that the burden of treatment related more
broadly to additional activities needed to manage eczema: ‘just
something else you have to remember to do’, e.g. always being
alert to avoiding possible triggers. These were viewed as
energy- or time-consuming, resulting in less attention given to
other children and/or family members. Parents also found it
difficult to maintain treatment routines outside the home as
they felt that their childcare or school was ill-equipped to man-
age treatment routines and avoid triggers.
Perceived trivialization/dismissal of eczema by others
A dominant belief was that eczema is misunderstood or dis-
missed as trivial by health professionals, friends, family and
wider society as ‘just a bit of dry skin’.16–18,21–23,25–27,31,43–49,51
Some studies highlighted how parents felt that family and
friends normalized sleep loss as being a normal part of parent-
ing, failing to recognize chronic sleep loss as related to eczema.
Others highlighted the perception that eczema is viewed in soci-
ety as a mundane, insignificant condition, common in child-
hood (i.e. most people know a child who has it mildly) and as
such it is something that people should ‘cope’ with. This was
linked to accounts of family, friends or strangers giving unso-
licited advice about eczema.
Hesitancy (patient/carer uncertainty) about eczema
treatments
Many studies reported common concerns, doubts and perceived
difficulties around eczema treatment, reflecting an implicit cau-
tion and uncertainty about topical treatments, particularly topi-
cal corticosteroids, and a general hesitancy towards regular or
long-term treatment. This hesitancy seemed to be exacerbated
by having received negative or conflicting advice about topical
treatments from health professionals and significant others.
Concerns about the perceived risk of topical
corticosteroids
A dominant concern was that using topical corticosteroids can
lead to skin damage, particularly skin thinning and possibly other
long-term negative effects, e.g. weakened bones, weight gain and
delayed growth. These seemed to be influenced by a shared
belief or social discourse that topical corticosteroids should be
treated with caution and apprehension.20,27,31–33,38,40 Some
studies highlighted how participants felt their concerns had
been reinforced by negative attitudes of health professionals and
significant others delivering messages such as the ‘risks of topi-
cal corticosteroid use outweigh the benefits’. Despite such con-
cerns, some studies found that while people were concerned
about potential risks, they found topical corticosteroids help-
ful/effective in managing their eczema and saw them as a ‘nec-
essary evil’.
Uncertainty about appropriate use of topical
corticosteroids
Participants reported a lack of confidence and low self-efficacy
in applying topical corticosteroids. This was related to uncer-
tainty and confusion about the appropriate use of topical cor-
ticosteroids in terms of dosage (e.g. strength/potency of
different preparations), where to apply, when to use, duration
of use and what constitutes a ‘thin layer’.27,31–33,40
Concerns about the constituents of emollients
Some studies highlighted people’s concerns about the con-
stituents of emollients, the unpleasant feel (thick, greasy,
messy) and odour of emollients and their uncertainty/
confusion about the range and choice of different emol-
lients.14,15,18,20,26–28,30,32,33,37,39,41,42,49,50 Some participants
felt that emollients are unnatural products containing chemicals
and expressed a desire for more ‘natural’ creams that they
deemed to be safer, or other treatments for eczema such as spe-
cial clothing. Other studies identified people’s mixed feelings
towards the range of different emollients creams and resultant
process of ‘trial and error’ in finding the ‘right’ cream.
Doubts about effectiveness of topical treatments
Many participants expressed doubts about topical treatments as
being ‘just some creams’ and perceived them as ineffective or
even that they make the eczema worse. Some studies high-
lighted a belief around becoming ‘resistant’ to both emollients
and topical corticosteroids if used regularly or over the long
term (i.e. skin becomes ‘used to’ treatment and treatments
lose effectiveness). Topical corticosteroids were frequently
viewed as effective only in the short term. A common frustra-
tion was that once you stop using them, the eczema just flares
up again, causing some to worry about ‘dependency’. In con-
trast, some studies highlighted the perceived effectiveness of
topical corticosteroids in terms of symptom relief and the
belief that topical corticosteroids are safe and effective if used
correctly and that uncontrolled eczema is a greater threat to
skin than treatment.26,27,31–35,37,38,41,52
Strategies to overcome perceived difficulties and concerns
As well as highlighting perceived difficulties, some studies
proposed strategies to address difficulties and help facilitate
topical treatment use.15,18,20,25,26,28,30 One study28 described
a range of responses that families adopted to overcome their
child’s resistance to topical treatments including involvement
of the child in treatment; distraction or games; using ‘bribes’
and, in a few cases, force. Other studies highlighted general
beliefs about what may make eczema treatment times easier,
such as establishing a routine, i.e. sticking to daily treatment
times to establish habits and finding the right treatment by
trial and error, i.e. discovering what works for the person
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with eczema in terms of effective, convenient topical treat-
ments that fit with daily life.
Some studies found that participants tried to make personal
adjustments/‘do their own thing’ (e.g. reducing dose) to help
mitigate their concerns and uncertainty about topical treat-
ments.37–40,42,50–52 Modifications to treatment regimens
included using creams that are less strong (or perceived to be
less strong), delaying the application of topical corticosteroids
for as long as possible and reducing the frequency of emol-
lient application. Although modifying treatment regimes may
lead to a sense of increased confidence and self-efficacy, it
may contribute to the underutilization of topical treatments
and poor eczema control.
Receiving conflicting and negative advice about topical
treatments
Our synthesis revealed common experiences of receiving
conflicting advice (contradictory opinions) and/or negative
opinions from health professionals regarding topical
treatments, especially around the safe use of topical corticos-
teroids.15,20,21,26,27,29,32,33,39,40 Conflicting advice was
received from different health profession specialties (e.g. pri-
mary care, paediatrics, dermatology, pharmacology), from dif-
ferent individuals within the same specialty (e.g. different
general practitioners), or between health professionals and
other sources (e.g. product information leaflets and medical
websites). This seemed to exacerbate concerns and uncertainty
about applying topical corticosteroids, which is likely to influ-
ence treatment use. Some studies suggested that conflicting
advice can lead people to seek information and advice else-
where, such as online, despite their doubts about the credibil-
ity of online information, which may add confusion.
Insufficient information and advice about eczema
Information and support provided by health professionals was
commonly seen as suboptimal in terms of quantity, detail and
timing. Our synthesis highlighted participants’ desire to have
more up-to-date, personalized information about treatment,
identifying flare-ups, and other aspects of living well with
eczema (e.g. strategies to reduce itch) as well as practical advice
around applying topical treatments, including demonstrations
from health professionals.16,18,21,24–27,29–31,33–35,39,42,43,50
Participants typically expressed a desire for patient-centred
management of eczema or shared decision-making. However,
one study42 noted that in the absence of sufficient eczema
information, provision and support can be experienced nega-
tively, with participants experiencing ‘involuntary autonomy’,
i.e. feeling ‘left to your own devices’ and having to self-man-
age by default.
Discussion
Our evidence synthesis highlights that people living with
eczema, particularly young people and parents of children
with eczema, often do not see eczema as a long-term condi-
tion. People are cautious about topical treatments for eczema,
especially topical corticosteroids and this appears to be exacer-
bated by experiences of conflicting and inconsistent advice
from health professionals and others. People with eczema and
their carers feel frustrated when others view eczema as mun-
dane, insignificant or ‘easy’, while it has significant psychoso-
cial impact.
In terms of the strengths and weaknesses of our study, this
systematic review and synthesis of qualitative studies provides
a comprehensive overview of a sizeable qualitative literature
on eczema and valuable insights into views and experiences of
managing eczema from the perspective of children and adults
with eczema, and parents/carers of children with eczema. We
used rigorous systematic review methods and identified many
well-reported studies from different countries. Key themes
were reported across many of the papers, suggesting that our
findings are robust. Valuable input from patient contributors
and the multidisciplinary team enabled a comprehensive inter-
pretation of findings.
We included only studies from peer-reviewed journals and
did not search the grey literature. We did not apply any lan-
guage restrictions to our search and included some non-Eng-
lish-language papers, but we might have missed relevant
papers not recorded on English-language databases. As with
other reviews, we are limited to data in the included primary
studies, which were predominantly conducted in European
countries. The synthesis process is inherently interpretive, and
this synthesis presents one possible interpretation of the data.
Our study was undertaken as part of a larger project to
develop online resources to support eczema self-care, which
may have influenced our interpretations. Another research
team would likely generate a different interpretation.
In comparison with other studies, our findings are supported
by a previous synthesis of qualitative studies of treatment adher-
ence, which suggests that people dislike taking regular medica-
tion or treatment on a long-term basis as it reminds them of the
chronicity of their illness, which many do not accept.53 It may
be that the perception of needing to limit the use of other types
of medication, such as antibiotics (due to antibiotic resistance),
may fuel people’s general reluctance to taking medication and
so clear, consistent advice about eczema treatments is needed.
It is interesting to note that it was often parents and young
people who focused on a ‘cure’ for eczema. It is likely that
adults with eczema had been living with the condition for
longer and had more experience of its long-term and fluctuat-
ing nature. Commonly reported messages around ‘you or your
child will grow out of it’ can feel like dismissal, especially
when mismatched with actual experiences. Traditional clinical
teaching promotes eczema as primarily a childhood condition
that generally remits by 10–12 years of age.54 However,
recent research suggests that this may not be true for many.55
Managing expectations accordingly might help to reduce dis-
appointment for those who don’t grow out of it.56
In conclusion, much qualitative research on eczema has
focused on the views and experiences of adults and
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parents/carers. Although more recent research has shed light
on the impact of eczema on children,57 further research is
needed from the perspective of children and young people.
There is a need for health professionals to address beliefs and
concerns about eczema treatments, address the significant psy-
chosocial impacts of eczema and burdensome nature of treat-
ments, including practical, clear, consistent advice about
treatments and strategies to overcome perceived difficulties.
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